Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Gelesis received early financing of $500.0K on 2006-12-26.
| Series | Round size | Date |
|---|---|---|
| Series A | $500K | 12/2006 |
| Series B | $16M | 01/2008 |
| Series B | $3.6M | 05/2011 |
| Series Unknown | $2.6M | 06/2011 |
| Series E | $12M | 05/2014 |
| Private Equity | $22M | 03/2015 |
| Private Equity | $31.5M | 12/2015 |
| Private Equity | $30M | 02/2018 |
| Grant | $10.6M | 04/2019 |
| Private Equity | $84M | 12/2019 |
| Investors | Security type |
|---|---|
| PureTech Health | Series A |
| Cape Family Fund | Series A |
| PureTech Health | Series B |
| OrbiMed Advisors | Series B |
| QIC BioVentures | Series B |
| Pritzker/Vlock Family Office | Series E |
| PureTech Health | Series E |
| Pritzker/Vlock Family Office | Private Equity |
| PureTech Health | Private Equity |
| Cormorant Asset Management | Private Equity |
| INVESCO LTD. | Private Equity |
| Vitruvian Partners | Private Equity |
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Gilead Sciences | - | $28.8B | 11,800 | - |
| Nektar Therapeutics | - | $98.4M | 718 | - |
| GlobeImmune | - | $6.5M | 22 | - |
| Alzheon | - | $8.0M | 5 | - |
| Diffusion Pharmaceuticals | - | $7.3M | 10 | - |
| Detect Lab | - | $9.2M | 3,000 | - |
| Midwest Hernia Institute | - | $560,000 | 5 | - |
| Jones John R MD | - | - | - | - |
Zippia gives an in-depth look into the details of Gelesis, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Gelesis. The employee data is based on information from people who have self-reported their past or current employments at Gelesis. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Gelesis. The data presented on this page does not represent the view of Gelesis and its employees or that of Zippia.
Gelesis may also be known as or be related to Gelesis, Gelesis Inc and Gelesis, Inc.